Form 8-K AUXILIUM PHARMACEUTICALS For: Sep 09

Go back to Form 8-K AUXILIUM PHARMACEUTICALS For: Sep 09

Auxilium's (AUXL) Restructuring Seen as Positive by MKM

September 10, 2014 11:44 AM EDT

MKM affirms Auxilium (Nasdaq; AUXL) at Buy with a price target of $26 following news that the company plans to reduce annual expenses by at least $75 million and headcount by 30 percent.

MKM noted the following key points:Auxilium's merger with QLT is expected to close by October 31, will significantly... More